Merck & CO., INC. (MRK) SEC Filings — 2024

Filings

• Merck & Co. Files 8-K: Director Changes, Compensation, Bylaws — 8-K · Nov 22, 2024
• Merck & Co. Files 3Q24 10-Q Report — 10-Q · Nov 6, 2024
• Merck & CO., INC. SC 13G/A Filing — SC 13G/A · Nov 6, 2024
• Merck & Co. Files 8-K on Financials — 8-K · Oct 31, 2024
• Merck & Co. Files 10-Q for Q2 2024 — 10-Q · Aug 5, 2024
• Merck & Co. Files 8-K on Financials and Debt — 8-K · Jul 30, 2024
• Merck & Co. Files 8-K on Shareholder Votes and Notes — 8-K · May 30, 2024
• Merck & Co., Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 3, 2024
• Merck & Co. Files 8-K on Financial Condition — 8-K · Apr 25, 2024
• Merck & Co., Inc. Files Amendment to Annual Report (10-K/A) — 10-K/A · Apr 11, 2024
• Merck & Co., Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 26, 2024
• Merck 8-K Signals Potential Leadership or Compensation Changes — 8-K · Feb 20, 2024
• Merck & CO., INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Merck Files 8-K for Corporate Communications, Rule 425 & 14a-12 — 8-K · Feb 1, 2024
• BlackRock Amends Merck Stake: Passive Investment Continues — SC 13G/A · Jan 26, 2024
• Merck Discloses Passive Stake in Evaxion Biotech — SC 13G · Jan 23, 2024